Home News Page 2

News

Featured Image Courtesy: Byondis Biopharmaceuticals (previously Synthon Biopharmaceuticals, Nijmegen, The Netherlands.

New Phase I Study Investigates [Vic-]Trastuzumab Duocarmazine + Niraparib in HER2-Expressing Solid Tumors

As part of a new study focusing on advanced targeting human epidermal growth factor receptor-2 (HER2-) expressing cancers, including...

ADC Therapeutics On Track to File BLA for Loncastuximab Tesirine for R/R DLBCL later...

This week Swiss-based ADC Therapeutics, a late clinical-stage oncology-focused biotechnology company pioneering the development of antibody-drug conjugates (ADCs) for...

Daiichi Sankyo and AstraZeneca to Jointly Evaluate Patritumab Deruxtecan + Osimertinib in EGFR-Mutated...

Earlier this week Daiichi Sankyo and AstraZeneca confirmed that the companies had entered into a clinical trial collaboration with...

U.S. FDA Approves Belantamab Mafodotin as a Monotherapy in R/R Multiple Myeloma

The U.S. Food and Drug Administration has approved* belantamab mafodotin-blmf (Blenrep®; GlaxoSmithKline/GSK) as a monotherapy treatment for adult patients...

Piramal Pharma Solutions and Bolt Biotherapeutics Sign Production Agreement

Piramal Pharma Solutions, a contract development and manufacturing organization (CDMO) and San Francisco-based biotech Bolt Bioterapeutics have signed a...

Daiichi Sankyo and AstraZeneca Agree on Global Development and Commercialization for DS-1062

Daiichi Sankyo and AstraZeneca confirmed entering into a global development and commercialization agreement for datopotamab deruxtecan also know as...

Tubulis Closes a € 10.7 Million Series A financing to Accelerate ADC Development

Tubulis, which spun out in 2019 from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and the Ludwig Maximilians...

Synaffix and ADC Therapeutics Expand Collaboration

The Netherlands-based biotechnology company Synaffix and Swiss-based ADC Therapeutics have expanded the existing collaboration between the companies to explore...
Featured Image: Women and the power to fight breast cancer Courtesy: © 2017. Fotolia. Used with permission.

Daiichi Sankyo and Gustave Roussy Sign Multi-year and Multi-study Adaptive Phase II Trial Collaboration

Daiichi Sankyo and Gustave Roussy have signed a multi-year, multi-study research collaboration for the ongoing development of DS-1062 and patritumab...

Proof-of-Concept: A Novel Strategy for the Production of Site-specific Antibody-drug Conjugates

Researchers of USC/University of Southern California‘s School of Pharmacy have engineered a new, faster way to develop ADCs.In a...